NEW YORK, April 03, 2017 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of USANA Health Sciences, Inc. ("USANA") (NYSE:USNA) between March 14, 2014 and February 7, 2017. You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the District of Utah. To get more information go to:
http://www.zlk.com/pslra/usana-health-sciences-inc?wire=3
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that throughout the Class Period Defendants made materially false and/or misleading statements and/or failed to disclose material adverse facts, including that: (i) the Company's BabyCare Ltd. subsidiary had engaged in improper reimbursement practices in China; (ii) these practices constituted violations of the Foreign Corrupt Practices Act; (iii) as such, the Company’s China revenues were in part the product of unlawful conduct and unlikely to be sustainable; (iv) the foregoing conduct was likely to subject the Company to significant regulatory scrutiny; and (v) as a result of the foregoing, USANA’s public statements were materially false and misleading at all relevant times
On February 7, 2017, post-market, USANA disclosed that “[t]he Company is voluntarily conducting an internal investigation of its China operations, BabyCare Ltd. The investigation focuses on compliance with the Foreign Corrupt Practices Act . . . and certain conduct and policies at BabyCare, including BabyCare's expense reimbursement policies.”
If you suffered a loss in USANA you have until April 14, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


Nvidia Denies Upfront Payment Requirement for H200 AI Chips Amid China Export Scrutiny
Chevron Set to Expand Venezuela Operations as U.S. Signals Shift on Oil Sanctions
Zhipu AI Launches GLM-Image Model Trained on Huawei Chips, Boosting China’s AI Self-Reliance Drive
AbbVie Commits $100 Billion to U.S. Investment in Drug Pricing Deal With Trump Administration
SK Hynix to Invest $13 Billion in Advanced Chip Packaging Plant as AI Memory Demand Surges
Netflix Plans All-Cash Bid for Warner Bros Discovery Studios Amid Intense Hollywood Takeover Battle
Starlink Internet Remains Active in Iran Despite Nationwide Blackout
Trump Pushes Tech Giants to Absorb AI Data Center Power Costs, Citing Microsoft Changes
HSBC Expands UAE Presence With New Asset Management Business and Onshore Funds
BlackRock to Cut Around 250 Jobs as CEO Larry Fink Pushes Strategic Shift
Saks Global Files for Bankruptcy Protection Amid Mounting Luxury Retail Pressures
Tesla, EEOC Move Toward Mediation in Racial Harassment Lawsuit
Taiwan Issues Arrest Warrant for OnePlus CEO Over Alleged Illegal Recruitment Activities
BlueScope Steel Announces A$1 Special Dividend After Asset Sales
U.S. Lawmakers Raise Alarm Over Trump Approval of Nvidia AI Chip Sales to China
TSMC Set to Post Record Q4 Profit as AI Chip Demand Accelerates
Amazon Reviews Supplier Costs as U.S.–China Tariffs Ease 



